iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Fortis Healthcare Ltd Option Chain

Add as a Preferred Source on Google
841.45
(-0.32%)
Jan 22, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
00%₹148.05 0%700--
--720₹0.25 -85.29%4,6500%
--740₹0.15 -78.57%11,625200%
--750--
1,5500%₹87.55 0%760₹0.9 20%57,350640%
--770₹1.1 57.14%4,650500%
7750%₹70 0%780₹1.05 23.52%10,075-61.76%
--790₹1.3 23.8%40,30020.93%
2,3250%₹44 0%800₹2.1 68%1,98,400228.20%
1,550-50%₹38.45 -3.27%810₹3.45 102.94%80,6008.33%
15,500566.66%₹26.9 -5.44%820₹5 117.39%4,91,35023.58%
20,150550%₹26 42.07%830₹7.5 105.47%4,18,5006.09%
79,050251.72%₹19 45.03%840₹10.5 66.66%51,925-54.72%
3,68,125159.56%₹14 66.66%850₹14.85 40.75%1,98,40014.28%
3,90,600250%₹9 102.24%860₹23 33.72%46,50025%
3,97,57511.27%₹5.7 165.11%870₹32.9 34.56%39,525-45.16%
2,18,55034.92%₹3.5 169.23%880₹40.6 21.92%95,325-10.86%
2,18,5500.71%₹1.5 114.28%890₹49.75 10.06%68,975-19.09%
4,92,125-16.66%₹1.15 91.66%900₹53.25 -1.93%2,03,825-0.75%
1,41,050-26.01%₹0.5 0%910₹57 -8.36%1,13,925-3.92%
2,09,250-21.51%₹0.35 -12.5%920₹79.7 14.84%1,13,925-2%
1,26,325-31.51%₹0.3 -33.33%930₹89.8 9.37%59,675-4.93%
1,50,350-14.15%₹0.15 -57.14%940₹90.55 -2.63%46,500-3.22%
2,78,225-14.92%₹0.35 0%950₹109.7 5.17%67,425-7.44%
91,450-20.80%₹0.25 -16.66%960₹110 11.67%17,050-8.33%
47,275-15.27%₹0.25 -28.57%970₹125 0%13,1750%
1,37,1754.73%₹0.3 -25%980₹131 60.73%38,750-41.17%
58,125-3.84%₹0.2 -42.85%990₹79.15 0%13,9500%
2,89,075-23.72%₹0.1 -66.66%1,000₹155 0.97%62,000-1.23%
28,675-28.84%₹0.15 -57.14%1,010--
27,9000%₹0.05 -75%1,020₹172.5 33.1%2,3250%
72,0750%₹0.2 0%1,030--
18,6000%₹0.2 0%1,040₹204 0%1,5500%
41,0750%₹0.1 -33.33%1,060₹225 0%1,5500%
--1,080₹210.9 0%00%
25,575-5.71%₹0.2 100%1,100--

Fortis Health.: Related NEWS

Fortis Healthcare unit inks 15-year pact with RR Lifesciences

Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.

2 Sep 2025|12:33 PM
Read More
Fortis Healthcare’s Q1 Profit Rises 10% to ₹152 Crore

Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.

7 Aug 2025|03:48 PM
Read More
Fortis Healthcare’s Subsidiary IHL Faces ₹76.19 Crore Tax Demand

The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.

4 Apr 2025|12:05 PM
Read More
Top Stocks for Today - 4th April 2025

Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.

4 Apr 2025|07:43 AM
Read More
Fortis Healthcare Q3 Profit Soars 89.5% YoY, Revenue Up 14.8%

EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.

9 Feb 2025|10:53 PM
Read More
Fortis Healthcare Boosts Stake in Agilus Diagnostics with ₹429 Crore IFC Deal

The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.

23 Dec 2024|11:59 AM
Read More
Fortis Healthcare Reports 1.6% Profit Growth, 12.3% Revenue Increase in Q2

Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.

12 Nov 2024|12:03 PM
Read More
Fortis Buys Out PE Investors in Diagnostics Arm

Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.

9 Aug 2024|08:32 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.